NASDAQ:CLVS - Clovis Oncology Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$25.32 +1.14 (+4.71 %)
(As of 02/22/2019 04:00 PM ET)
Previous Close$24.18
Today's Range$24.00 - $25.40
52-Week Range$11.50 - $65.24
Volume1.23 million shs
Average Volume1.59 million shs
Market Capitalization$1.33 billion
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

Clovis Oncology (NASDAQ:CLVS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
13 Wall Street analysts have issued ratings and price targets for Clovis Oncology in the last 12 months. Their average twelve-month price target is $53.8520, suggesting that the stock has a possible upside of 112.69%. The high price target for CLVS is $110.00 and the low price target for CLVS is $16.00. There are currently 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.772.772.692.92
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $53.8520$57.0520$57.0520$83.0578
Price Target Upside: 112.69% upside159.21% upside356.05% upside76.57% upside

Clovis Oncology (NASDAQ:CLVS) Consensus Price Target History

Price Target History for Clovis Oncology (NASDAQ:CLVS)

Clovis Oncology (NASDAQ:CLVS) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/13/2019HC WainwrightInitiated CoverageBuy ➝ Buy$40.00MediumView Rating Details
12/11/2018GabelliReiterated RatingBuyLowView Rating Details
12/4/2018Leerink SwannUpgradeMarket Perform ➝ OutperformHighView Rating Details
10/31/2018BarclaysLower Price TargetOverweight ➝ Overweight$58.00 ➝ $40.00HighView Rating Details
10/31/2018Piper Jaffray CompaniesLower Price TargetNeutral$18.00HighView Rating Details
10/31/2018SunTrust BanksDowngradeBuy$20.00 ➝ $70.00HighView Rating Details
10/31/2018JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$71.00 ➝ $16.00HighView Rating Details
10/30/2018OppenheimerReiterated RatingHoldHighView Rating Details
9/17/2018GuggenheimInitiated CoverageBuyLowView Rating Details
6/12/2018Royal Bank of CanadaReiterated RatingBuy$73.00HighView Rating Details
4/26/2018Credit Suisse GroupSet Price TargetBuy$86.00LowView Rating Details
4/9/2018Bank of AmericaLower Price TargetBuy$90.00 ➝ $55.52HighView Rating Details
2/27/2018Stifel NicolausLower Price TargetBuy ➝ Buy$125.00 ➝ $110.00MediumView Rating Details
2/22/2018Evercore ISIUpgradeIn-Line ➝ Outperform$72.00HighView Rating Details
11/2/2017Morgan StanleyLower Price TargetOverweight$89.00 ➝ $86.00N/AView Rating Details
6/20/2017Goldman Sachs GroupReiterated RatingNeutral$67.00 ➝ $90.00HighView Rating Details
6/20/2017Janney Montgomery ScottUpgradeNeutral ➝ BuyMediumView Rating Details
6/19/2017Chardan CapitalUpgradeSell ➝ Neutral$36.00 ➝ $50.00HighView Rating Details
(Data available from 2/23/2017 forward)
This page was last updated on 2/23/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel